PROFILES - Connect with RTRN Researchers

Otelio Randall
Title Dr
Faculty Rank Professor
Degree
Institution Howard University
Department INTERNAL MEDICINE
Clusters Other
Address
HU
City Washington
State DC
Postal Code 20059
Telephone
Fax
Email
QR Barcode

Narrative icon

 
Not Available

NIH Awarded Grants icon

  Research projects funded by the National Institutes of Health (NIH), the Centers for Disease Control (CDC), the Food and Drug Administration (FDA), and the Department of Veterans Affairs (VA)

Loading
Please wait
1.
2009MOMHAA5M01RR010284-14
2.
2008AASK-CO5M01RR010284-13
3.
2008MOMHAA5M01RR010284-13
4.
2007AASK Cohort Study3U01DK045387-13S1
5.
2007AASK-CO5M01RR010284-12
6.
2006AASK-CO2M01RR010284-11
7.
2006AASK Cohort Study5U01DK045387-13
8.
2005TM--STUDY #25M01RR010284-10
9.
2005AASK Cohort Study5U01DK045387-12
10.
2005AASK-CO5M01RR010284-10
11.
2005HERBAL STUDY5M01RR010284-10
12.
2004IMT Study5M01RR010284-09
13.
2004AASK Cohort Study5M01RR010284-09
14.
2004Herbal Study5M01RR010284-09
15.
2004AASK Cohort Study5U01DK045387-11
16.
2003AASK Cohort Study2U01DK045387-10
17.
2002AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK)5M01RR010284-07
18.
2002EVALUATION &REDUCTION OF RISK FACTORS FOR CARDIOVASCULAR DISEASE (OB5M01RR010284-07
19.
2002LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION (LIFE)5M01RR010284-07
20.
2002AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION3U01DK045387-09S1
21.
2001AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION5U01DK045387-09
22.
2000AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK)5M01RR010284-05
23.
2000EVALUATION &REDUCTION OF RISK FACTORS FOR CARDIOVASCULAR DISEASE (OB5M01RR010284-05
24.
2000LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION (LIFE)5M01RR010284-05
25.
2000AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION5U01DK045387-08
26.
1999AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK)5M01RR010284-04
27.
1999HYPERTENSIVE OPTIMAL TREATMENT (HOT)5M01RR010284-04
28.
1999AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION5U01DK045387-07
29.
1999LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION (LIFE)5M01RR010284-04
30.
1999EVALUATION &REDUCTION OF RISK FACTORS FOR CARDIOVASCULAR DISEASE (OB5M01RR010284-04
31.
1998AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION5U01DK045387-06
32.
1998LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION (LIFE)5M01RR010284-03
33.
1998AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK)5M01RR010284-03
34.
1998HYPERTENSIVE OPTIMAL TREATMENT (HOT)5M01RR010284-03
35.
1997AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION3U01DK045387-04S5
36.
1997LOSARTAN INTERVENTION FOR ENDPOINTS (LIFE)5M01RR010284-02
37.
1997AFRICAN AMERICAN KIDNEY DISEASE &HYPERTENSION (AASK)--ANTIHYPERTENSIVE DRUGS5M01RR010284-02
38.
1997HYPERTENSIVE OPTIMAL TREATMENT (HOT)5M01RR010284-02
39.
1997AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION5U01DK045387-05
40.
1996AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION3U01DK045387-04S3
41.
1996AFRICAN AMERICAN KIDNEY DISEASE &HYPERTENSION (AASK)--ANTIHYPERTENSIVE DRUGS1M01RR010284-01A1
42.
1996PREVENTIVE CARDIOLOGY--EVALUATION/REDUCTION OF RISK FACTORS FOR CVD--OBESITY1M01RR010284-01A1
43.
1996AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION3U01DK045387-04S4
44.
1995AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION3U01DK045387-04S2
45.
1994PREVENTIVE CARDIOLOGY ACADEMIC AWARD5K07HL002269-05
46.
1994AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION2U01DK045387-04
47.
1994KIDNEY DISEASE AND HYPERTENSION5U01DK045387-03
48.
1994AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSIO3U01DK045387-04S1
49.
1993PREVENTIVE CARDIOLOGY ACADEMIC AWARD NHLBI5K07HL002269-04
50.
1993KIDNEY DISEASE AND HYPERTENSION IN BLACKS--PILOT STUDY3U01DK045387-02S1
51.
1993KIDNEY DISEASE AND HYPERTENSION IN BLACKS--PILOT STUDY3U01DK045387-02S3
52.
1993KIDNEY DISEASE AND HYPERTENSION IN BLACKS--PILOT STUDY3U01DK045387-02S2
53.
1993KIDNEY DISEASE AND HYPERTENSION IN BLACKS--PILOT STUDY5U01DK045387-02
54.
1992KIDNEY DISEASE AND HYPERTENSION IN BLACKS--PILOT STUDY1U01DK045387-01
55.
1992PREVENTIVE CARDIOLOGY ACADEMIC AWARD5K07HL002269-03
56.
1991PREVENTIVE CARDIOLOGY ACADEMIC AWARD5K07HL002269-02
57.
1990PREVENTIVE CARDIOLOGY ACADEMIC AWARD NHLBI1K07HL002269-01A1

Publications icon

  Check NIH Public Access Policy Compliance

Loading
Please wait
1. Retta TM, Kwagyn J, Randall OS. Non-adherence in Hypertension Management Deficit in Information or Trust? J Natl Med Assoc. 2017 Spring; 109(1):60-62.
2. Duraimani S, Schneider RH, Randall OS, Nidich SI, Xu S, Ketete M, Rainforth MA, Gaylord-King C, Salerno JW, Fagan J. Effects of Lifestyle Modification on Telomerase Gene Expression in Hypertensive Patients: A Pilot Trial of Stress Reduction and Health Education Programs in African Americans. PLoS One. 2015; 10(11):e0142689.
3. Mellman TA, Brown TS, Kobayashi I, Abu-Bader SH, Lavela J, Altaee D, McLaughlin L, Randall OS. Blood Pressure Dipping and Urban Stressors in Young Adult African Americans. Ann Behav Med. 2015 Aug; 49(4):622-7.
4. Kwagyan J, Retta TM, Ketete M, Bettencourt CN, Maqbool AR, Xu S, Randall OS. Obesity and Cardiovascular Diseases in a High-Risk Population: Evidence-Based Approach to CHD Risk Reduction. Ethn Dis. 2015; 25(2):208-13.
5. Randall O, Kwagyan J, Retta T, Jamerson K, Pogue V, Norris K, Ketete M, Xu S, Greene T, Wang X, Agodoa L. Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosis. Int J Nephrol. 2013; 2013:120167.
6. Peterson GE, de Backer T, Contreras G, Wang X, Kendrick C, Greene T, Appel LJ, Randall OS, Lea J, Smogorzewski M, Vagaonescu T, Phillips RA. Relationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease. Hypertension. 2013 Sep; 62(3):518-25.
7. Cherqaoui R, Kassim TA, Kwagyan J, Freeman C, Nunlee-Bland G, Ketete M, Xu S, Randall OS. The metabolically healthy but obese phenotype in African Americans. J Clin Hypertens (Greenwich). 2012 Feb; 14(2):92-6.
8. Napan S, Kwagyan J, Randall OS, Xu S, Ketete M, Maqbool AR. Nocturnal blood pressure nondipping in obese African-Americans. Blood Press Monit. 2011 Jun; 16(3):111-6.
9. Contreras G, Hu B, Astor BC, Greene T, Erlinger T, Kusek JW, Lipkowitz M, Lewis JA, Randall OS, Hebert L, Wright JT, Kendrick CA, Gassman J, Bakris G, Kopple JD, Appel LJ. Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol. 2010 Dec; 21(12):2131-42.
10. Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010 Sep 02; 363(10):918-29.
11. Kwagyan J, Hussein S, Xu S, Ketete M, Maqbool AR, Schneider RH, Randall OS. The relationship between flow-mediated dilatation of the brachial artery and intima-media thickness of the carotid artery to Framingham risk scores in older African Americans. J Clin Hypertens (Greenwich). 2009 Dec; 11(12):713-9.
12. Grimm RH, Davis BR, Piller LB, Cutler JA, Margolis KL, Barzilay J, Dart RA, Graumlich JF, Murden RA, Randall OS. Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome? J Clin Hypertens (Greenwich). 2009 Sep; 11(9):466-74.
13. Mellman TA, Brown DD, Jenifer ES, Hipolito MM, Randall OS. Posttraumatic stress disorder and nocturnal blood pressure dipping in young adult African Americans. Psychosom Med. 2009 Jul; 71(6):627-30.
14. Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreras G, Gassman J, Lash J, Miller ER, Randall O, Wang X, McClellan W. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis. 2008 May; 51(5):732-40.
15. Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT, Wang X, Greene T, Appel LJ, Lewis J. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis. 2006 Nov; 48(5):739-51.
16. Thornley-Brown D, Wang X, Wright JT, Randall OS, Miller ER, Lash JP, Gassman J, Contreras G, Appel LJ, Agodoa LY, Cheek D. Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. Arch Intern Med. 2006 Apr 10; 166(7):797-805.
17. Randall OS, Kwagyan J, Huang Z, Xu S, Ketete M, Maqbool AR. Effect of diet and exercise on pulse pressure and cardiac function in morbid obesity: analysis of 24-hour ambulatory blood pressure. J Clin Hypertens (Greenwich). 2005 Aug; 7(8):455-63.
18. Kwagyan J, Tabe CE, Xu S, Maqbool AR, Gordeuk VR, Randall OS. The impact of body mass index on pulse pressure in obesity. J Hypertens. 2005 Mar; 23(3):619-24.
19. Retta TM, Randall OS. Hypertension and concomitant diseases: a guide for evidence-based therapy. J Natl Med Assoc. 2004 Apr; 96(4):450-60.
20. Julius S, Alderman MH, Beevers G, Dahlöf B, Devereux RB, Douglas JG, Edelman JM, Harris KE, Kjeldsen SE, Nesbitt S, Randall OS, Wright JT. Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol. 2004 Mar 17; 43(6):1047-55.
21. Randall OS, Feseha HB, Illoh K, Xu S, Ketete M, Kwagyan J, Tilghman C, Wrenn M. Response of lipoprotein(a) levels to therapeutic life-style change in obese African-Americans. Atherosclerosis. 2004 Jan; 172(1):155-60.
22. Randall OS, Retta TM, Kwagyan J, Gordeuk VR, Xu S, Maqbool AR, Ketete M, Obisesan TO. Obese African Americans: the prevalence of dyslipidemia, hypertension, and diabetes mellitus. Ethn Dis. 2004; 14(3):384-8.
23. Gassman JJ, Greene T, Wright JT, Agodoa L, Bakris G, Beck GJ, Douglas J, Jamerson K, Lewis J, Kutner M, Randall OS, Wang SR. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S154-65.
24. Wright JT, Agodoa L, Contreras G, Greene T, Douglas JG, Lash J, Randall O, Rogers N, Smith MC, Massry S. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med. 2002 Jul 22; 162(14):1636-43.
25. Randall OS, Feseha HB, Retta TM, Bettencourt CN, Xu S, Ketete M, Maqbool AR. Effects of a low-calorie, low-salt diet and treadmill exercise on atherosclerotic risk factors in obese African-American women. Am J Cardiol. 2002 Jun 01; 89(11):1311-3.
26. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT, Xu S. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001 Jun 06; 285(21):2719-28.
27. Barzilay JI, Jones CL, Davis BR, Basile JN, Goff DC, Ciocon JO, Sweeney ME, Randall OS. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2001 Apr; 24(4):654-8.
28. Hall WD, Kusek JW, Kirk KA, Appel LJ, Schulman G, Agodoa LY, Glassock R, Grim C, Randall OS, Massry SG. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study. Am J Kidney Dis. 1997 May; 29(5):720-8.
29. Wright JT, Kusek JW, Toto RD, Lee JY, Agodoa LY, Kirk KA, Randall OS, Glassock R. Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996 Aug; 17(4 Suppl):3S-16S.
30. Randall OS, Retta TM, Ordor OE, Courtney BL. Can risk factor modification reduce cardiovascular morbidity and mortality in minority populations? Prev Med. 1996 Jan-Feb; 25(1):61-2.
31. Randall OS. Panel A wrap-up: concepts, considerations, and challenges in managing hypertension in African-American patients. J Natl Med Assoc. 1995 Aug; 87(8 Suppl):618-21.
32. Retta TM, Afre GM, Randall OS. Dietary management of blood pressure. J Assoc Acad Minor Phys. 1994; 5(4):147-51.
33. Retta TM, Afre GM, Randall OS. Hypertensive renal disease in blacks. Transplant Proc. 1993 Aug; 25(4):2421-2.
34. Randall OS, Wilks J, Ferguson JJ. Total arterial compliance: differences between spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. J Assoc Acad Minor Phys. 1992; 3(1):24-9.
35. Randall OS. Physiology and pathophysiology of hypertension. J Assoc Acad Minor Phys. 1991; 2(4):151-5.
36. Peniston RL, Randall OS. Coronary artery disease in black Americans 1920-1960: the shaping of medical opinion. J Natl Med Assoc. 1989 May; 81(5):591-5, 598-600.
37. Ferguson JJ, Randall OS. Systolic, diastolic, and combined hypertension. Differences between groups. Arch Intern Med. 1986 Jun; 146(6):1090-3.
38. Randall OS. Effect of arterial compliance on systolic blood pressure and cardiac function. Clin Exp Hypertens A. 1982; 4(7):1045-57.
39. Esler M, Zweifler A, Randall O, Julius S, DeQuattro V. The determinants of plasma-renin activity in essential hypertension. Ann Intern Med. 1978 Jun; 88(6):746-52.
40. Randall O, Esler M, Culp B, Julius S, Zweifler A. Determinants of baroreflex sensitivity in man. J Lab Clin Med. 1978 Mar; 91(3):514-9.
41. Esler M, Zweifler A, Randall O, DeQuattro V. Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol. Clin Pharmacol Ther. 1977 Sep; 22(3):299-308.
42. Esler M, Zweifler A, Randall O, Julius S, DeQuattro V. Agreement among three different indices of sympathetic nervous system activity in essential hypertension. Mayo Clin Proc. 1977 Jun; 52(6):379-82.
43. Esler M, Julius S, Zweifler A, Randall O, Harburg E, Gardiner H, DeQuattro V. Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med. 1977 Feb 24; 296(8):405-11.
44. Esler M, Julius S, Randall O, DeQuattro V, Zweifler A. High-renin essential hypertension: adrenergic cardiovascular correlates. Clin Sci Mol Med Suppl. 1976 Dec; 3:181s-184s.
45. Esler M, Randall O, Bennett J, Zweifler A, Julius S, Rydelek P. Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet. 1976 Jul 17; 2(7977):115-8.
46. Randall OS, Esler MD, Calfee RV, Bulloch GF, Maisel AS, Culp B. Arterial compliance in hypertension. Aust N Z J Med. 1976; 6 suppl 2:49-59.

Research Resources icon

Funding Opportunities icon

Browse active NIH & NSF funding opportunities, requests for applications (RFAs), and program announcements (PAs)

Publications Timeline

Top MeSH Keywords

Tree Map of Keyword Semantic Groups (Categories)

Left-click a node to move down the tree, right-click the graph to move back up the tree

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile:
 
Keyword
Last Name
Institution
 
Keywords
African Americans
Hypertension
Obesity
Blood Pressure
Cardiovascular Diseases
See all (204) keywords
See all (3) people See all (60) people Search for (2) people
Feedback

RTRN Collaboration and Professional Networking Feedback